InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Nicaise Claude, Directeur. Insider active across 1 company, notably Sarepta Therapeutics, Inc.. Cumulatively, 6 disclosures have been logged. Activity tracked since 7 March 2022. The latest transaction was filed on 29 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Nicaise Claude is Director at Sarepta Therapeutics, Inc. The declarant has 6 filings in total. Across the 6 recent filings available, the modal transaction nature is Attribution, with a period running from 2022-03-08 to 2026-01-29.